article · Zenodo (CERN European Organization for Nuclear Research)
Oral Squamous Cell Carcinoma (OSCC) early diagnosis is crucial in improving patient survival. The traditional diagnostic methods such as visual inspection and histopathology are time-consuming, subjective and rely heavily on the expertise of the clinician and may result in delayed diagnosis and treatment, thereby decreasing the success of intervention. One potential solution is the use of artificial intelligence (AI), especially deep learning, which can detect lesions quickly, non-invasively, and accurately. But there has been little research on deep learning–based oral cancer detection in African countries. The aim of this research is to create a deep learning model for automatic detection of oral lesions using YOLOv8 algorithm from radiographic (X-ray) images. Images of 613 annotated images across six classes (normal, cancer-inner, cancer-outer, herpes-inner, herpes-outer, and ulcer) were obtained from Roboflow and then split into a training, validation, and test set of 70%, 15%, and 15%, respectively, with images resized to 640×640 pixels. The accuracy, precision, recall, F1-score, mAP@50, and mAP@50–95 were used to assess the model's performance. The model achieved a mAP score of 0.84 and 0.56 in mAP@50 and mAP@50-95 respectively, and the overall precision, recall and f1 score were 0.88, 0.75 and 0.81 respectively, best performance in cancer classes. Results show that YOLOv8 can be used to complete the early oral cancer screening in resource-limited environments.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.20794912
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.